| Biotechnology Industry | Healthcare Sector | Dr. Liangzhi Xie Ph.D. CEO | XSHE Exchange | - ISIN |
| CN Country | 1,021 Employees | 15 May 2026 Last Dividend | 30 Mar 2022 Last Split | - IPO Date |
Sino Biological, Inc. is a prominent provider of recombinant protein and antibody reagents designed to meet the needs of life science researchers across the globe. Since its establishment in 2016, the company has positioned itself as a key player in the biotechnology field, supplying a wide range of high-quality products and services. Operating out of its headquartered in Beijing, China, Sino Biological caters to various sectors within the scientific community, including academic research institutions, biotech companies, and pharmaceutical corporations. The company's mission is to accelerate the pace of scientific discovery by offering reliable and innovative solutions that facilitate research in critical areas such as cancer research, cardiovascular biology, and neurosciences among others.
Recombinant Proteins: Sino Biological offers an extensive catalog of high-quality recombinant proteins to support research in areas such as immunology, cancer, and stem cells. These proteins are essential tools for understanding disease mechanisms and developing therapeutic strategies.
Antibodies: The company provides a broad range of antibodies, including monoclonal, polyclonal, and conjugated antibodies. These are carefully developed to ensure high specificity and sensitivity for various applications in cell signaling, neuroscience, and more.
cDNA Clones: Sino Biological’s collection of cDNA clones is an invaluable resource for gene expression studies, enabling researchers to investigate gene function and regulation across a variety of organisms and conditions.
Kits: The company produces kits designed for the precise detection and quantification of biological substances. These kits simplify complex analyses in areas such as epigenetics and cell biology.
Custom Services: Beyond its extensive product offerings, Sino Biological also provides custom services tailored to meet specific research needs. These services include protein production, antibody development and production, biological assay, and protein expression services.
Pre-Clinical Production Technology Services: Sino Biological offers technology services for the pre-clinical production of monoclonal antibody drug candidates, facilitating the development of next-generation therapeutics.